Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

OPIUM TINCTURE 10 MG/ML

Morphine
$2.5952per ML
DEA Schedule CII

Strength

10 mg/mL

Manufacturer

Edenbridge Pharmaceuticals LLC

NDC

42799021701

Classification

Generic

Dosage Form

TINCTURE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MORPHINE

Approval Type

Unapproved

On Market Since

7/15/2010

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

-3.8%

3M

-11.2%

6M

-24.4%

1Y

-8.7%

3Y

-19.0%

5Y

-10.4%

All

-36.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TRAMADOL HCL 50 MG TABLET
Generic
00093005805•Teva Pharmaceuticals USA Inc.
$0.0239
per EA
TRAMADOL HCL 50 MG TABLET
Generic
00093330101•Teva Pharmaceuticals USA Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
00093330105•Teva Pharmaceuticals USA Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
00904749661•Major Pharmaceuticals
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
16571071601•Rising Pharma Holdings Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
16571071610•Rising Pharma Holdings Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
16571071650•Rising Pharma Holdings Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
29300035501•Unichem Pharmaceuticals (USA) Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
29300035505•Unichem Pharmaceuticals (USA) Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
29300035510•Unichem Pharmaceuticals (USA) Inc.
$0.0241
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy